|
|
|
Insider
Information: |
Schwab Andrew J. |
Relationship: |
10% Owner |
City: |
Burlington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
16 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
10,770,294 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$22,933,794 |
|
|
Total
Shares |
10,770,294 |
|
|
Total
Value |
$22,933,794 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
18
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
18
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-18.0
|
Percentage
Gain/Loss : |
0.0%
|
-1,674.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Flexion Therapeutics Inc |
FLXN |
Director, 10% Owner |
|
0 |
2014-02-18 |
1,512,076 |
Premium* |
|
Cidara Therapeutics, Inc. |
CDTX |
10% Owner |
|
0 |
2015-04-20 |
50,412 |
Premium* |
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
Former 10% holder |
2018-07-20 |
0 |
2019-06-21 |
94,489 |
Premium* |
|
Arvinas Holding Company, Llc |
ARVN |
10% Owner |
2018-10-01 |
0 |
2019-09-16 |
1,002 |
Premium* |
|
Ideaya Biosciences, Inc. |
IDYA |
10% Owner |
|
0 |
2019-05-28 |
500,000 |
Premium* |
|
Aprea Therapeutics, Inc. |
APRE |
10% Owner |
|
0 |
2019-10-02 |
12,670 |
Premium* |
|
Cabaletta Bio, Inc. |
CABA |
10% Owner |
2019-10-29 |
0 |
2021-11-01 |
333,144 |
Premium* |
|
Scpharmaceuticals Inc. |
SCPH |
10% Owner |
2020-05-26 |
0 |
2022-10-10 |
410,268 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
5:01 Acquisition Corp. |
FVAM |
Co-CEO, Director, 10% ... |
2020-10-16 |
0 |
2020-11-12 |
365,126 |
Premium* |
|
Q32 Bio Inc |
QTTB |
10% Owner |
2020-12-14 |
0 |
2020-12-22 |
181,435 |
Premium* |
|
Vor Biopharma Inc. |
VOR |
10% Owner |
2021-02-09 |
0 |
2021-11-16 |
1,766,634 |
Premium* |
|
Rallybio Corp |
RLYB |
10% Owner |
|
0 |
2021-07-29 |
3,575,340 |
Premium* |
|
Entrada Therapeutics, Inc. |
TRDA |
10% Owner |
|
0 |
2021-11-02 |
1,132,357 |
Premium* |
|
Pear Therapeutics, Inc |
PEAR |
10% Owner |
2021-12-03 |
0 |
2023-04-10 |
200,000 |
Premium* |
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2023-02-23 |
0 |
2024-02-14 |
635,341 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
|
2024-02-14 |
4 |
S |
$14.90 |
$12,292,500 |
I/I |
(825,000) |
635,341 |
0 |
- |
|
ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
|
2024-01-31 |
4 |
S |
$15.00 |
$7,500,000 |
I/I |
(500,000) |
771,983 |
0 |
- |
|
ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
|
2023-08-24 |
4 |
S |
$16.00 |
$7,040,000 |
I/I |
(440,000) |
887,507 |
0 |
- |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2023-04-10 |
4 |
S |
$0.12 |
$1,985,294 |
I/I |
(16,544,113) |
200,000 |
0 |
% |
|
ELVN |
Enliven Therapeutics Ord ... |
Director |
|
2023-02-23 |
4 |
A |
$0.00 |
$0 |
I/I |
5,798,475 |
960,383 |
0 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,135,786) |
0 |
0 |
- |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-11-15 |
4 |
S |
$2.52 |
$160,708 |
I/I |
(63,773) |
534,855 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-11-14 |
4 |
S |
$2.79 |
$33,837 |
I/I |
(12,128) |
537,406 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-11-11 |
4 |
S |
$3.19 |
$93,722 |
I/I |
(29,380) |
537,891 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-11-02 |
4 |
S |
$2.72 |
$28,772 |
I/I |
(10,578) |
539,066 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-11-01 |
4 |
S |
$2.80 |
$4,108 |
I/I |
(1,467) |
539,489 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-10-31 |
4 |
S |
$2.78 |
$117,216 |
I/I |
(42,164) |
539,548 |
0 |
% |
|
SCPH |
Scpharmaceuticals Inc. |
10% Owner |
|
2022-10-10 |
4 |
S |
$4.09 |
$2,300,486 |
I/I |
(562,466) |
410,268 |
0 |
- |
|
SCPH |
Scpharmaceuticals Inc. |
10% Owner |
|
2022-10-06 |
4 |
S |
$5.02 |
$188,421 |
I/I |
(37,534) |
497,304 |
0 |
- |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-09-16 |
4 |
S |
$1.75 |
$614 |
I/I |
(351) |
541,235 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-09-15 |
4 |
S |
$1.81 |
$493,678 |
I/I |
(272,750) |
541,249 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-09-14 |
4 |
S |
$1.94 |
$553,030 |
I/I |
(285,067) |
552,159 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-09-08 |
4 |
S |
$1.81 |
$550,823 |
I/I |
(304,322) |
563,562 |
0 |
% |
|
SCPH |
Scpharmaceuticals Inc. |
10% Owner |
|
2022-09-07 |
4 |
S |
$4.75 |
$950,000 |
I/I |
(200,000) |
503,112 |
0 |
- |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-09-07 |
4 |
S |
$1.92 |
$296,675 |
I/I |
(154,518) |
575,735 |
0 |
% |
|
SCPH |
Scpharmaceuticals Inc. |
10% Owner |
|
2022-09-06 |
4 |
S |
$5.52 |
$146,953 |
I/I |
(26,622) |
533,285 |
0 |
- |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-09-06 |
4 |
S |
$2.36 |
$734,338 |
I/I |
(311,160) |
581,916 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-08-18 |
4 |
S |
$1.55 |
$345,280 |
I/I |
(222,761) |
594,362 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-08-17 |
4 |
S |
$1.71 |
$17,232 |
I/I |
(10,077) |
603,272 |
0 |
% |
|
PEAR |
Pear Therapeutics, Inc |
10% Owner |
|
2022-08-16 |
4 |
S |
$1.78 |
$297,548 |
I/I |
(167,162) |
603,675 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|